Actenol side effects

May 31, 2008

Question:

Can it be possible that actenol causes memory loss where the build-up in calcium gets in the brain such as harding of the arteries?

Answer:

Atonel is a brand of risedronate and is used to treat osteoporosis. The drug slows down cells that break down bone and allows cell that build bone to work better. Risedronate does not deposit calcium in the brain or in the arteries. Risedronate doesn’t generally effect memory. The link below can provide more information on risedronate.

Read the rest of this entry »

Advertisements

Study Finds Flat Carbonated Beverages Ineffective For Hydration

May 31, 2008

An article published in the May issue of Archives of Disease in Childhood advises that children with acute vomiting and diarrhea should not use ‘flat’ carbonated beverages as an alternative for oral rehydration solution.

Patients with gastroenteritis (inflammation of the gastrointestinal tract) who are losing fluids, salts, and sugars due to diarrhea and vomiting typically ingest an oral rehydration solution that contains a certain balance of salts and sugars that can prevent dehydration. People often think that ‘flat’ carbonated beverages can be effective substitutes for these solutions – an especially appealing notion for children who are put off by the taste.
Read the rest of this entry »


Important First Steps To Creating A Synthetic Copycat Of A Living Cell

May 31, 2008

Researchers at The University of Nottingham have taken some important first steps to creating a synthetic copycat of a living cell, a leading science journal reports.

Dr Cameron Alexander and PhD student George Pasparakis in the University’s School of Pharmacy have used polymers – long-chain molecules – to construct capsule-like structures that have properties mimicking the surfaces of a real cell.

In work published as a ‘VIP paper’ in the journal Read the rest of this entry »


Society Of Urologic Oncology Meeting – Repeat Prostate Biopsy – When, Where And How?

May 31, 2008

ORLANDO, FL (UroToday.com) – Dr. Presti discussed that the adequacy of the initial biopsy must be assessed. One must examine how many cores were taken on the first biopsy. If it was only 6 cores, there was a 40% chance of finding cancer on the second biopsy as compared to 24% when an extended pattern was initially performed. Prostate volume was also important: there was an inverse trend between size and detection. PSA indices are useful on repeat biopsy. Free/total PSA outperforms other indices such as PSAD-TZ or PSAD. PSA kinetics has not been shown to be too useful in detection on repeat prostate biopsy.
Read the rest of this entry »


Two Years Of Quality Of Life Lost By Child Maltreatment Victims

May 31, 2008

Child maltreatment is associated with reductions in quality of life even decades later, according to a new University of Georgia study that finds that – on average – victims lose at least two years of quality of life.

UGA College of Public Health associate professor Phaedra Corso and her colleagues at the Centers for Disease Control and Prevention analyzed surveys of more than 6,000 people to assess the deficits in quality of life that victims suffer. Their results appear in the June issue of the Read the rest of this entry »


Patients With Stomach Cancer May Not Be Benefiting From A Major Study Showing Chemotherapy And Radiation Prolong Life After Surgery

May 30, 2008

New findings from Oregon Health & Science University Cancer Institute show significant numbers of patients nationwide who are not getting the recommended therapy after surgery to remove stomach cancer.

“We were surprised to learn that there are still many patients who are not receiving the gold standard of chemotherapy and radiation after surgery – despite compelling clinical data available since 2001. However, it is encouraging to see there has been a significant increase in the use of chemo-radiotherapy since it became the standard of care,” said Kristian Enestvedt, M.D., principal investigator, Department of Surgery, OHSU School of Medicine, OHSU Cancer Institute.
Read the rest of this entry »


National Black Anti-Tobacco Group To Withdraw Support For Tobacco Regulation Bill Because Of Menthol ‘Loophole’

May 30, 2008

The National African-American Tobacco Prevention Network this week is expected to officially announce its withdrawal of support for legislation that would allow FDA to regulate flavored tobacco products other than menthol cigarettes, according to the group’s executive director, the Atlanta Journal-Constitution reports (Young, Atlanta Journal-Constitution, 5/29).

The bill, sponsored by Sen. Edward Kennedy (D-Mass.) and 56 co-sponsors in the Senate, would give FDA the authority to remove addictive additives if they have proven to be harmful. Menthol-flavored products were excluded from the bill; such products represent more than 25% of the $70 billion tobacco market. Without the exclusion, the legislation might not have a chance of passing. The bill would also regulate advertisements and promotions for tobacco products.
Read the rest of this entry »